A pilot study discovered that the FSHR Ser680Asn genotype does not influence the follicular fluid hormonal profile or ovulation outcomes in cycles stimulated with varying gonadotropin preparations. The research, involving 40 women undergoing ART, compared two genetic variants and determined no significant impact on treatment results.
Read More
Chelsea Seals Deal with Tosin Adarabioyo: Fulham Defender Joins on Four-Year Contract
Roma's Summer Shake-Up: Houssem Aouar Among Potential Departures Amidst Major Squad Overhaul
Nipah Virus Outbreak in Kerala: One Dead and 60 High-Risk Contacts Being Monitored
Suresh Gopi Clears Air on Quitting Union Ministry Rumors Amidst New Film Commitments
Liverpool FC's First Black Player Howard Gayle Honored With Commemorative Mural
